Amphion Innovations PLC Directors' Dealings (9581L)
10 Julio 2014 - 3:10AM
UK Regulatory
TIDMAMP
RNS Number : 9581L
Amphion Innovations PLC
10 July 2014
Amphion Innovations plc
Directors' Dealings
Directors Receive Shares in Lieu of Fees
London and New York, 10 July 2014- Amphion Innovations plc (the
"Company") (LSE: AMP), the developer of medical and technology
businesses, announces that the Company has today issued 690,663
ordinary shares, representing 0.47% of the enlarged issued share
capital, to certain of its Board members as their directors' fees
for the fourth quarter of 2013 and the first two quarters of 2014,
priced at 2.175 pence, being the average of the closing mid-market
price for the five days leading up to the market close on 8 July
2014. Following this issue, the directors' shareholdings in the
Company are as follows:
Director Number of New Shares Total Shareholding Percentage of voting rights
R. James Macaleer 596,913 25,077,179 16.993%
Gerard Moufflet 93,750 956,250 0.648%
Director, Anthony Henfrey waived his fees for the fourth quarter
of 2013 as well as for the first two quarters of 2014.
Admission of the 690,663 new ordinary shares, ranking pari passu
with the existing ordinary shares, is expected on 16 July 2014.
Following this allotment the total issued share capital of the
Company will increase to 147,574,734 ordinary shares with each
share holding one voting right.
For further information please contact
Amphion Innovations
Charlie Morgan
+1 212 210 6224
Novella Communications
Tim Robertson / Ben Heath
+44 020 3151 7008
Panmure Gordon Limited
Freddy Crossley / Fred Walsh (Corporate Finance)
Charlie Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging
companies in the medical and technology sectors, by using a
focused, hands-on company building approach, based on decades of
experience in both the US and UK. Amphion has significant
shareholding in 7 Partner Companies developing proven technologies
targeting substantial commercial marketplaces. The Amphion model
has been refined to optimise the commercialisation of patents and
other intellectual property within the Partner Companies. The
Partner Companies collectively own or control over 200 separately
identified pieces of intellectual property, a number which grows
rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSGGUMUMUPCURU
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
Amphion Innovations (LSE:AMP)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024